414 related articles for article (PubMed ID: 26689967)
1. Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design.
Gorman J; Soto C; Yang MM; Davenport TM; Guttman M; Bailer RT; Chambers M; Chuang GY; DeKosky BJ; Doria-Rose NA; Druz A; Ernandes MJ; Georgiev IS; Jarosinski MC; Joyce MG; Lemmin TM; Leung S; Louder MK; McDaniel JR; Narpala S; Pancera M; Stuckey J; Wu X; Yang Y; Zhang B; Zhou T; ; Mullikin JC; Baxa U; Georgiou G; McDermott AB; Bonsignori M; Haynes BF; Moore PL; Morris L; Lee KK; Shapiro L; Mascola JR; Kwong PD
Nat Struct Mol Biol; 2016 Jan; 23(1):81-90. PubMed ID: 26689967
[TBL] [Abstract][Full Text] [Related]
2. Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop.
Cale EM; Gorman J; Radakovich NA; Crooks ET; Osawa K; Tong T; Li J; Nagarajan R; Ozorowski G; Ambrozak DR; Asokan M; Bailer RT; Bennici AK; Chen X; Doria-Rose NA; Druz A; Feng Y; Joyce MG; Louder MK; O'Dell S; Oliver C; Pancera M; Connors M; Hope TJ; Kepler TB; Wyatt RT; Ward AB; Georgiev IS; Kwong PD; Mascola JR; Binley JM
Immunity; 2017 May; 46(5):777-791.e10. PubMed ID: 28514685
[TBL] [Abstract][Full Text] [Related]
3. Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition.
Gorman J; Chuang GY; Lai YT; Shen CH; Boyington JC; Druz A; Geng H; Louder MK; McKee K; Rawi R; Verardi R; Yang Y; Zhang B; Doria-Rose NA; Lin B; Moore PL; Morris L; Shapiro L; Mascola JR; Kwong PD
Cell Rep; 2020 Apr; 31(1):107488. PubMed ID: 32268107
[TBL] [Abstract][Full Text] [Related]
4. Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus.
van Diepen MT; Chapman R; Douglass N; Galant S; Moore PL; Margolin E; Ximba P; Morris L; Rybicki EP; Williamson AL
J Virol; 2019 Apr; 93(8):. PubMed ID: 30760570
[TBL] [Abstract][Full Text] [Related]
5. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
[TBL] [Abstract][Full Text] [Related]
6. Stabilization of the V2 loop improves the presentation of V2 loop-associated broadly neutralizing antibody epitopes on HIV-1 envelope trimers.
de Taeye SW; Go EP; Sliepen K; de la Peña AT; Badal K; Medina-Ramírez M; Lee WH; Desaire H; Wilson IA; Moore JP; Ward AB; Sanders RW
J Biol Chem; 2019 Apr; 294(14):5616-5631. PubMed ID: 30728245
[TBL] [Abstract][Full Text] [Related]
7. Design and characterization of a germ-line targeting soluble, native-like, trimeric HIV-1 Env lacking key glycans from the V1V2-loop.
Ahmed S; Shrivastava T; Kumar R; Kumar M; Banerjee M; Kumar N; Bansal M; Das S; Samal S
Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129733. PubMed ID: 32949621
[TBL] [Abstract][Full Text] [Related]
8. Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies.
Wang H; Gristick HB; Scharf L; West AP; Galimidi RP; Seaman MS; Freund NT; Nussenzweig MC; Bjorkman PJ
Elife; 2017 May; 6():. PubMed ID: 28548638
[TBL] [Abstract][Full Text] [Related]
9. Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses.
Beltran-Pavez C; Bontjer I; Gonzalez N; Pernas M; Merino-Mansilla A; Olvera A; Miro JM; Brander C; Alcami J; Sanders RW; Sanchez-Merino V; Yuste E
J Virol; 2022 Jan; 96(1):e0134321. PubMed ID: 34668778
[TBL] [Abstract][Full Text] [Related]
10. Comparative Immunogenicity of Evolved V1V2-Deleted HIV-1 Envelope Glycoprotein Trimers.
Bontjer I; Melchers M; Tong T; van Montfort T; Eggink D; Montefiori D; Olson WC; Moore JP; Binley JM; Berkhout B; Sanders RW
PLoS One; 2013; 8(6):e67484. PubMed ID: 23840716
[TBL] [Abstract][Full Text] [Related]
11. New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency.
Doria-Rose NA; Bhiman JN; Roark RS; Schramm CA; Gorman J; Chuang GY; Pancera M; Cale EM; Ernandes MJ; Louder MK; Asokan M; Bailer RT; Druz A; Fraschilla IR; Garrett NJ; Jarosinski M; Lynch RM; McKee K; O'Dell S; Pegu A; Schmidt SD; Staupe RP; Sutton MS; Wang K; Wibmer CK; Haynes BF; Abdool-Karim S; Shapiro L; Kwong PD; Moore PL; Morris L; Mascola JR
J Virol; 2016 Jan; 90(1):76-91. PubMed ID: 26468542
[TBL] [Abstract][Full Text] [Related]
12. VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA.
Jia M; Liberatore RA; Guo Y; Chan KW; Pan R; Lu H; Waltari E; Mittler E; Chandran K; Finzi A; Kaufmann DE; Seaman MS; Ho DD; Shapiro L; Sheng Z; Kong XP; Bieniasz PD; Wu X
Cell Host Microbe; 2020 Jun; 27(6):963-975.e5. PubMed ID: 32315598
[TBL] [Abstract][Full Text] [Related]
13. Binding of inferred germline precursors of broadly neutralizing HIV-1 antibodies to native-like envelope trimers.
Sliepen K; Medina-Ramírez M; Yasmeen A; Moore JP; Klasse PJ; Sanders RW
Virology; 2015 Dec; 486():116-20. PubMed ID: 26433050
[TBL] [Abstract][Full Text] [Related]
14. Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV envelope.
Doores KJ; Kong L; Krumm SA; Le KM; Sok D; Laserson U; Garces F; Poignard P; Wilson IA; Burton DR
J Virol; 2015 Jan; 89(2):1105-18. PubMed ID: 25378488
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability.
Dubrovskaya V; Tran K; Ozorowski G; Guenaga J; Wilson R; Bale S; Cottrell CA; Turner HL; Seabright G; O'Dell S; Torres JL; Yang L; Feng Y; Leaman DP; Vázquez Bernat N; Liban T; Louder M; McKee K; Bailer RT; Movsesyan A; Doria-Rose NA; Pancera M; Karlsson Hedestam GB; Zwick MB; Crispin M; Mascola JR; Ward AB; Wyatt RT
Immunity; 2019 Nov; 51(5):915-929.e7. PubMed ID: 31732167
[TBL] [Abstract][Full Text] [Related]
16. Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models.
Saunders KO; Verkoczy LK; Jiang C; Zhang J; Parks R; Chen H; Housman M; Bouton-Verville H; Shen X; Trama AM; Scearce R; Sutherland L; Santra S; Newman A; Eaton A; Xu K; Georgiev IS; Joyce MG; Tomaras GD; Bonsignori M; Reed SG; Salazar A; Mascola JR; Moody MA; Cain DW; Centlivre M; Zurawski S; Zurawski G; Erickson HP; Kwong PD; Alam SM; Levy Y; Montefiori DC; Haynes BF
Cell Rep; 2017 Dec; 21(13):3681-3690. PubMed ID: 29281818
[TBL] [Abstract][Full Text] [Related]
17. Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization.
Kong R; Duan H; Sheng Z; Xu K; Acharya P; Chen X; Cheng C; Dingens AS; Gorman J; Sastry M; Shen CH; Zhang B; Zhou T; Chuang GY; Chao CW; Gu Y; Jafari AJ; Louder MK; O'Dell S; Rowshan AP; Viox EG; Wang Y; Choi CW; Corcoran MM; Corrigan AR; Dandey VP; Eng ET; Geng H; Foulds KE; Guo Y; Kwon YD; Lin B; Liu K; Mason RD; Nason MC; Ohr TY; Ou L; Rawi R; Sarfo EK; Schön A; Todd JP; Wang S; Wei H; Wu W; ; Mullikin JC; Bailer RT; Doria-Rose NA; Karlsson Hedestam GB; Scorpio DG; Overbaugh J; Bloom JD; Carragher B; Potter CS; Shapiro L; Kwong PD; Mascola JR
Cell; 2019 Jul; 178(3):567-584.e19. PubMed ID: 31348886
[TBL] [Abstract][Full Text] [Related]
18. Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies.
Torrents de la Peña A; Sanders RW
Retrovirology; 2018 Sep; 15(1):63. PubMed ID: 30208933
[TBL] [Abstract][Full Text] [Related]
19. Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer.
Kong L; Torrents de la Peña A; Deller MC; Garces F; Sliepen K; Hua Y; Stanfield RL; Sanders RW; Wilson IA
Acta Crystallogr D Biol Crystallogr; 2015 Oct; 71(Pt 10):2099-108. PubMed ID: 26457433
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers.
Schorcht A; van den Kerkhof TLGM; Cottrell CA; Allen JD; Torres JL; Behrens AJ; Schermer EE; Burger JA; de Taeye SW; Torrents de la Peña A; Bontjer I; Gumbs S; Ozorowski G; LaBranche CC; de Val N; Yasmeen A; Klasse PJ; Montefiori DC; Moore JP; Schuitemaker H; Crispin M; van Gils MJ; Ward AB; Sanders RW
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
